Juniarto AZ, Noppe G, Maharani N, van den Akker E, Susanto R, MH Faradz S, H. de Jong F, L.S. Drop S. Salivary 17-hydroxyprogesterone (17-OHP) and androstenedione in monitoring efficacy of treatment among Indonesian Congenital Adrenal Hyperplasia Patients. J ASEAN Fed Endocr Soc [Internet]. 2014May23 [cited 2024May2];27(2):203. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/38